2014
DOI: 10.1016/j.biochi.2013.08.009
|View full text |Cite
|
Sign up to set email alerts
|

Central nervous system pathology in MFP2 deficiency: Insights from general and conditional knockout mouse models

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
14
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 13 publications
(15 citation statements)
references
References 73 publications
1
14
0
Order By: Relevance
“…Patients with severe MFP2 deficiency suffer from neonatal hypotonia, brain malformations, seizures, and psychomotor retardation, and their life time typically does not exceed 1 y. [ 23 ]. Similarly, the KO mouse models manifest motor impairment, ataxia, and die within 6 mo.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Patients with severe MFP2 deficiency suffer from neonatal hypotonia, brain malformations, seizures, and psychomotor retardation, and their life time typically does not exceed 1 y. [ 23 ]. Similarly, the KO mouse models manifest motor impairment, ataxia, and die within 6 mo.…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, the KO mouse models manifest motor impairment, ataxia, and die within 6 mo. [ 23 ]. Oil Red O staining of the brain sections of Mfp2 -/- mice showed significant lipid accumulation within several brain regions, most specifically within the ependymal cells of the whole ventricular system [ 21 ].…”
Section: Discussionmentioning
confidence: 99%
“…Increased incorporation of VLCFAs into the phospholipids of the inner mitochondrial membrane might destabilize OXPHOS complexes inducing electron leakage and ROS production, finally compromising cell physiology (López-Erauskin et al 2013 ; Fourcade et al 2014 ). However, disease severity did not correlate with VLCFA elevation in the different conditional MFP2 −/− strains (Verheijden et al 2013 , 2014 ). Thus, accumulation of VLCFAs might not be mainly responsible for the ROS-induced and inflammatory pathology observed in many peroxisomal disorders.…”
Section: News From the Brain: Unravelling The Mysterious Role Of Peromentioning
confidence: 99%
“…There is no infiltration of peripheral monocytes, no systemic inflammation and no contribution of peripheral pathology to the clinical deterioration in Mfp2 −/− mice (Jia et al, 2003 ; Huyghe et al, 2006b , c ; Verheijden et al, 2013 , 2015 ). We previously generated a mouse model in which the HSD17B4 gene was conditionally inactivated in neural progenitor cells ( NestinCre + Mfp2 loxP/loxP , further denoted as Nestin-Mfp2 −/− mice) resulting in the complete depletion of the enzyme in neurons, astrocytes and oligodendrocytes (Verheijden et al, 2013 , 2014 ). Whereas constitutive Mfp2 −/− mice (further denoted as Mfp2 −/− ) develop chronic and extensive microgliosis and die within 4–6 months, Nestin-Mfp2 −/− mice only develop minor microgliosis and survive up to 12 months.…”
Section: Introductionmentioning
confidence: 99%
“…Whereas constitutive Mfp2 −/− mice (further denoted as Mfp2 −/− ) develop chronic and extensive microgliosis and die within 4–6 months, Nestin-Mfp2 −/− mice only develop minor microgliosis and survive up to 12 months. In contrast to the severe lethargic pathology in Mfp2 −/− mice, Nestin-Mfp2 −/− mice develop a milder clinical decline dominated by ataxia at a preterminal stage of disease (Verheijden et al, 2013 , 2014 ).…”
Section: Introductionmentioning
confidence: 99%